-
English Version
Good Pharmacovigilance Practices (GVP) Guidelines
$39.99Good pharmacovigilance practices (GVP) are a set of measures designed to facilitate the performance of pharmacovigilance in separate countries. The course explores the activities related to detecting and preventing adverse effects and problems associated with medicines.
English Version
Good Production Practices (GPP) for Cannabis
$79.99This training program is designed to provide employees with a comprehensive understanding of Canadian Good Production Practices (GPP) for cannabis. GPP is a set of quality standards that ensure the safety, quality, and consistency of cannabis products.
Introduction to GMP
$29.99The Introduction to Good Manufacturing Practices (GMP) is a shortened training program that includes an introduction to good manufacturing practices, information on maintaining product quality, the scope of GMP rules, a section on cleaning and sanitation, a look into proper documentation, Validation, Data Integrity and concludes with a summary.
Preparing and Submitting Summary Reports for Marketed Drugs and Natural Health Products
$39.99This training program is designed to equip regulatory affairs professionals with the knowledge and skills necessary to prepare and submit compliant summary reports for marketed drugs and natural health products in accordance with Health Canada’s guidance document. The training focuses on the regulatory requirements, reporting timelines, data collection methodologies, and documentation standards mandated by Health Canada for monitoring the safety profile of post-market products.
Reporting Adverse Reactions to Marketed Health Products
$39.99This comprehensive training program aims to equip healthcare professionals, pharmaceutical personnel, and other relevant stakeholders with the knowledge and skills necessary to effectively identify, document, and report adverse reactions (ARs) associated with marketed health products. The training will cover regulatory guidelines, best practices, reporting mechanisms, and the importance of pharmacovigilance in ensuring patient safety.